Granisetron Extended-Release Injection and Insulin aspart, recombinant Subcutaneous
Determining the interaction of Granisetron Extended-Release Injection and Insulin aspart, recombinant Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: granisetron
Brand name: Sustol, Kytril, Sancuso
Synonyms: Granisetron
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Granisetron Extended-Release Injection-Insulin degludec
- Granisetron Extended-Release Injection-Insulin Degludec (U-100) Prefilled Pens
- Granisetron Extended-Release Injection-Insulin Degludec (U-100) Vials
- Granisetron Extended-Release Injection-Insulin Degludec (U-200) Prefilled Pens
- Granisetron Extended-Release Injection-Insulin degludec and liraglutide
- Granisetron Extended-Release Injection-Insulin degludec and liraglutide Subcutaneous
- Insulin aspart, recombinant Subcutaneous-Granisetron Hydrochloride
- Insulin aspart, recombinant Subcutaneous-Granisetron injection
- Insulin aspart, recombinant Subcutaneous-Granisetron Oral, Intravenous
- Insulin aspart, recombinant Subcutaneous-Granisetron Tablets
- Insulin aspart, recombinant Subcutaneous-Granisetron transdermal
- Insulin aspart, recombinant Subcutaneous-Granisetron Transdermal System